Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylated annexin A2 (p-ANXA2) is a post-translationally modified form of annexin A2, a calcium-dependent phospholipid-binding protein. Phosphorylation, typically on tyrosine or serine residues, regulates its structure and function in cellular processes like membrane trafficking, aggregation, and exocytosis. It interacts with partners like S100A10/S100A4 and F-actin. Altered expression or phosphorylation is linked to cancer progression and fibrinolytic disorders.
Modulation of membrane binding and protein-protein interactions via phosphorylation-dependent conformational changes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylated Annexin A2 (p-ANXA2).